[HTML][HTML] Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration …
Ophthalmology, 2020•Elsevier
Purpose To establish a process to evaluate and standardize a state-of-the-art nomenclature
for reporting neovascular age-related macular degeneration (AMD) data. Design Consensus
meeting. Participants An international panel of retina specialists, imaging and image reading
center experts, and ocular pathologists. Methods During several meetings organized under
the auspices of the Macula Society, an international study group discussed and codified a
set nomenclature framework for classifying the subtypes of neovascular AMD and …
for reporting neovascular age-related macular degeneration (AMD) data. Design Consensus
meeting. Participants An international panel of retina specialists, imaging and image reading
center experts, and ocular pathologists. Methods During several meetings organized under
the auspices of the Macula Society, an international study group discussed and codified a
set nomenclature framework for classifying the subtypes of neovascular AMD and …
Purpose
To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data.
Design
Consensus meeting.
Participants
An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists.
Methods
During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components.
Main Outcome Measures
A consensus classification of neovascular AMD.
Results
The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated.
Conclusions
The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
Elsevier